Skip to main content
logo
Anatara Lifesciences Ltd (ASX:ANR)
Australia flag Australia · Delayed Price · Currency is AUD
0.0100
0.00 (0.00%)
Sep 1, 2026, 12:31 PM AEST

Anatara Lifesciences Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
0.320.320.970.64--
Revenue Growth
-48.95%-67.16%50.53%---
Gross Profit
0.320.32-0.63-0.1-1.6-0.75
Operating Income
-0.94-0.94-1.96-1.46-2.05-2.53
Net Income
-0.93-0.93-1.95-1.45-2.02-2.53
Earnings Per Share
-0.00-0.00-0.01-0.01-0.02-0.04
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
0.470.470.10.980.41.17
Total Debt
--0.41--0.07
Net Cash (Debt)
0.470.47-0.310.980.41.1
Net Cash Growth
-56.61%--144.80%-63.67%-67.05%
Net Cash Per Share
0.000.00-0.000.010.000.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-0.34-0.34-2.27-1.25-2.26-2.23
Capital Expenditures
-----0-0.01
Free Cash Flow
-0.34-0.34-2.27-1.25-2.26-2.24
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%-65.39%-16.29%--
Operating Margin
-293.69%-293.69%-201.83%-226.56%--
Pretax Margin
-293.10%-293.10%-201.63%-225.34%--
Profit Margin
-293.10%-293.10%-201.63%-225.34%--
FCF Margin
-106.54%-106.54%-234.36%-193.69%--

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-75.0075.0075.0075.0075.00
PS Ratio
9.929.921.1012.47--